Evidence map›Paper›PMID 39598463›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Evolving Clinical Features of Diabetic Ketoacidosis: The Impact of SGLT2 Inhibitors.

Selin Genc, Bahri Evren, Onur Selcuk Yigit, Ibrahim Sahin, Ramazan Dayanan, Aleksandra Klisic, Ayse Erturk, Filiz Mercantepe

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Selin GencDepartment of Endocrinology and Metabolism, Konya State Hospital, Konya 42250, Türkiye.ORCID 0000-0001-5525-3476
Bahri EvrenDepartment of Endocrinology and Metabolism, Faculty of Medicine, Inonu University, Malatya 44280, Türkiye.
Onur Selcuk YigitDepartment of Internal Medicine, Ordu State Hospital, Ordu 52200, Türkiye.
Ibrahim SahinDepartment of Endocrinology and Metabolism, Memorial Sisli Hospital, Istanbul 34384, Türkiye.ORCID 0000-0002-6231-0034
Ramazan DayananDepartment of Endocrinology and Metabolism, Batman Training and Research Hospital, Batman 72070, Türkiye.
Aleksandra KlisicFaculty of Medicine, University of Montenegro, 81000 Podgorica, Montenegro.ORCID 0000-0001-7870-0996
Ayse ErturkDepartment of Infection Disease, Faculty of Medicine, Recep Tayyip Erdogan University, Rize 53100, Türkiye.
Filiz MercantepeDepartment of Endocrinology and Metabolism, Faculty of Medicine, Recep Tayyip Erdogan University, Rize 53100, Türkiye.ORCID 0000-0002-4325-1534

Funding

The Recep Tayyip Erdogan University Development Foundation 02024007031026
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diabetic ketoacidosis (DKA)euglycemic diabetic ketoacidosis (euDKA)genitourinary infection (GUI)latent autoimmune diabetes in adults (LADA)sodium–glucose co-transporter-2 inhibitor (SGLT2-i)type 1 diabetes mellitus (T1DM)

Identifiers

PMID39598463
PMCPMC11597506

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.